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Abstract  
Despite the huge diversity of antibacterial compounds, bacterial resistance to first 
choice antibiotics has been drastically increasing. Moreover, the association between 
multi-resistant microorganisms and nosocomial infections highlight the problem, and 
the urgent need for solutions. Natural resources have been exploited in the last years and 
among them mushrooms could be an alternative as source of new antimicrobials. In this 
review we present an overview about the antimicrobial properties of mushroom extracts, 
highlight some of the active compounds identified including low and high molecular 
weight (LMW and HMW, respectively) compounds. LMW compounds are mainly 
secondary metabolites, such as sesquiterpenes and other terpenes, steroids, 
anthraquinones, benzoic acid derivatives, and quinolines, but also primary metabolites 
such as oxalic acid. HMW compounds are mainly peptides and proteins. Data available 
from literature indicate a higher antimicrobial activity of mushroom extracts against 
Gram-positive bacteria. Among all the mushrooms, Lentinus edodes is the most studied 
species and seems to have a broad antimicrobial action against both Gram-postive and 
Gram-negative bacteria. Plectasin peptide, obtained from Pseudoplectania nigrella, is 
the isolated compound with highest antimicrobial activity against Gram-positive 
bacteria, while 2-aminoquinoline, isolated from Leucopaxillus albissimus, presents the 
highest antimicrobial activity against Gram-negative bacteria. 
 
Key words: Mushrooms; Basidiomycetes; Antimicrobials; Gram positive bacteria; 
Gram negative bacteria   
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Abbreviations 
CSAP Cordyceps sinensis antibacterial protein 
CFU Colony-forming unities 
ERSP Erythromycin-resistant Streptococcus pyogenes  
HMW High molecular weight compounds 
IC50 Concentration inhibiting 50% of the growth 
IZD Internal zone diameter 
LMW Low molecular weight compounds 
M Mycelium 
MIC Minimal inhibitory concentration 
MRSA Methicillin-resistant Staphylococcus aureus  
MRSE Methicillin-resistant Staphylococcus epidermidis  
PABA para-Aminobenzoic acid  
PRSP Penicillin-resistant Streptococcus pneumonia  
VREF Vancomycin-resistant Enterococcus faecium  
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Introduction 
Mushrooms bioactivity 
For a long time mushrooms have been playing an important role in several aspects of 
the human activity. Edible mushrooms, for example, are used extensively in cooking 
and make part of low calorie diets. Mythology is extensively garnished by mushrooms, 
typically associated with gnomes, fairies and other fairytale personages. The 
psychedelic and consciousness expansion properties of some species have pushed 
mushrooms to become part of some religions. Even toxic mushrooms have found a 
place of relevance, because of the uniqueness of their compounds that evolved naturally 
as a protection against consumption [1].  
Wild and cultivated mushrooms contain a huge diversity of biomolecules with 
nutritional [2] and/or medicinal properties [3-5]. Due to these properties, they have been 
recognized as functional foods, and as a source for the development of medicines and 
nutraceuticals. Fruiting bodies, mycelia and spores accumulate a variety of bioactive 
metabolites with immunomodulatory, cardiovascular, liver protective, anti-fibrotic, anti-
inflammatory, anti-diabetic, anti-viral, antioxidant, antitumor, and antimicrobial 
properties [3-14] 
The frequent use of mushrooms is based on three main assumptions: first they are used 
as part of regular diet for their nutritional value (since they are rich in water, minerals, 
proteins, fibers and carbohydrates, and are low caloric foods due to low content in fat 
[2]); secondly, fruiting bodies are also appreciated for their delicacy (they are 
palatability enhancers of flavor and aroma when associated to other foods); thirdly, 
mushrooms are widely used for medicinal purposes. Their pharmacological action and 
therapeutic interest in promoting human health have been known for thousands of years 
[5, 15,16].  
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In particular, mushrooms could be a source of natural antibiotics, which can be low or 
high molecular weight (LMW and HMW, respectively) compounds. LMW compounds 
are mainly secondary metabolites such as sesquiterpenes and other terpenes, steroids, 
antraquinone and benzoic acid derivatives, and quinolines, but also primary metabolites 
such as oxalic acid (Figure 1). HMW compounds include mainly peptides and proteins.  
It is estimated that there are about 140,000 species of mushrooms on earth and of these 
only 22,000 are known and only a small percentage (5%) was investigated. Therefore, 
there is much to explore about mushrooms properties and potential applications [4].  
 
Bacteria and drug discovery 
The development of antibiotics has been one of the most important scientific 
achievements of the last seventy years. These compounds act in several ways, by 
interfering in metabolic processes or in the organism structures [17]. The mechanism of 
action is mostly related with interferences in the synthesis of cell wall, modification of 
plasmatic membrane permeability, interferences in chromosomes replication or in 
protein synthesis [18]. The cell wall is responsible for the shape and rigidity of bacterial 
cells, acting as osmotic barrier [19]. The peptidoglycan content in the cell wall varies 
between 10% and 60% for Gram negative and Gram positive bacteria, respectively [20, 
21].  
Antiparietal antibiotics act in one of the phases of peptidoglycan synthesis, being 
classified according to that phase. Phosphomycin, D-cycloserine, glycopeptides 
(bacitracin, vancomycin, teicoplanin) and beta-lactams (penicillins, cephalosporins, 
carbapenemics and monobactamics) are some examples of this group [22]. 
Otherwise, other antibiotics such as ascolistin and daptomycin act at the cell membrane 
level. Aminoglycosides and tetracyclines, macrolides, oxazolidines, quinupristin and 
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dalfopristin, clindamycin and chloramphenicol inibhit protein synthesis by interfering 
with 30s or 50s ribosomal subunits. Quinolones, rifampicin and metronidazol inibhit 
nucleic acids synthesis..Sulfonamides and trimetoprim are antimetabolic antibiotics that 
inhibit the metabolic chain of para-aminobenzoic acid (PABA), essential to cell growth 
[23].  
Despite the huge diversity of antibacterial compounds, bacterial resistance to first 
choice antibiotics has been drastically increasing. Some examples are microorganisms 
such as Klebsiella spp. and Escherichia coli producing broad spectrum beta-lactamase 
or presenting resistance to third generation cephalosporins. Other examples include 
methicillin-resistant Staphylococcus aureus (MRSA), Enterococcus spp. resistant to 
vancomycin [24, 25], Acinetobacter spp. with increasing resistance to carbapenems and 
colistin [26], and also Pseudomonas spp. resistant to aminoglycosides, carbapenemics 
and/or cephalosporins [24].   
Diseases that were easily healed are nowadays becoming a serious problem due to the 
emergent antibiotics resistance [27,28]. The association between multi-resistant 
microorganisms and hospital infections certainly highlighted the problem and the urgent 
need for solutions [29]. In 2010, the World Health Organization advised all the 
countries to implement control procedures for the propagation of drug multi-resistant 
bacteria, highlighting the risks associated to the absence of alternative therapies against 
those microorganisms [30]. 
Therefore, the research of new antimicrobial substances effective against pathogenic 
microorganisms resistant to current drugs is crucial. New groups of organisms such as 
marine have been increasingly exploredin the last years and among them mushrooms 
could be an alternative as source of new antimicrobials. In this review we provide an 
overview about the antimicrobial properties of mushroom extracts and highlight 
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selected compounds. The databases searched were Medline (1980 to March 2012) and 
Web of Science (2001 to March 2012) including scientific articles and conference 
proceedings. Search terms were: ‘mushrooms’, ‘antimicrobial activity’ and 
‘antimicrobials’. An exhaustive literature search was performed but only mushroom 
extracts and isolated compounds with positive results were included.  
 
Antimicrobial activity against gram positive bacteria 
Methodologies 
Different methodologies have been used to acess antimicrobial activity of mushrooms 
extracts and compounds, including  microdilution method, disk diffusion method, agar 
streak dilution method based in radial diffusion and a method with incorportation of the 
extract in the culture medium and further determination of colonies. Therefore, the 
results for antimicrobial activity are expressed in different unities (Tables 1 and 2).  
Microdilution method comprises microdilutions of the extract in liquid medium using 
microplates to determine MIC (minimal inhibitory concentration) or IC50 (concentration 
inhibiting 50% of the growth) values. In disk difusion method, the extract is 
incorporated in disks at different concentrations, and the halo of growth inhibition is 
determined and represented by IZD (internal zone diameter) values. The agar streak 
dilution method based in radial diffusion is most widely used in extracts and implies the 
extract application in circular holes made in solid medium. The result might be 
expressed in IZD or MIC values. Regarding the fourth method, the extract is 
incorporated in the culture medium and, then, colony-forming unities (CFU) are 
determined.   
 
Mushroom extracts with antimicrobial activity 
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Numerous mushroom extracts have been reported as having antimicrobial activity 
against Gram-positive bacteria (Table 1).  
Agaricus bisporus, the most cultivated mushroom in the world, should be highlighted.  
Its methanolic extract revealed MIC = 5µg/mL against Bacillus subtilis even lower than 
the standard ampicillin (MIC = 12.5 µg/mL) [31] and also showed activity against 
Bacillus cereus, Micrococcus luteus, Micrococcus flavus, Staphylococcus aureus and 
Staphylococcus epidermidis [15, 32, 33]. Other Agaricus species also demonstrate 
antimicrobial activity. Agaricus bitorquis and Agaricus essettei methanolic extracts 
showed inhibitory effect upon all the tested Gram-positive bacteria [15]. Agaricus 
silvicola methanolic extract also revealed antimicrobial properties against Bacillus 
cereus (MIC = 5µg/mL), Bacillus subtilis (MIC = 50µg/mL), and against 
Staphylococcus aureus (MIC = 5µg/mL), lower than the standard ampicillin (MIC = 
6.25µg/mL) [31]. The mycelium of Agaricus cf. nigrecentulus and Tyromyces 
duracinus (ethyl acetate extracts) showed activity only against Staphylococcus 
saprophyticus [34]. 
The ethanolic extracts of Armillaria mellea mycelium showed antibacterial effect 
against Sarcina lutea, however no activity was observed upon other Gram-positive 
bacteria [35]. However, ethanolic extract of their fruiting bodies showed broad-
spectrum antimicrobial activity [36]. 
The most studied mushrooms of the genus Boletus is Boletus edulis. Its methanolic 
mushroom showed lower antimicrobial activity than other species studied by Ozen et al. 
[32]. Nevertheless, Barros et al. [31] reported MIC = 5µg/mL against Staphylococcus 
aureus lower than ampicilin (MIC = 6.25µg/mL). 
Cantharellus cibarius methanolic extract demonstrated good activity against Bacillus 
subtilis and Staphylococcus aureus [31, 32, 37]. This mushroom had activity against 
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Bacillus cereus in some studies [32, 37], but it was not so effective in other report [31], 
which could be related to the different methodologies used to evaluate antimicrobial 
activity.  
Clitocybe alexandri methanolic extract presented significant activity against Bacillus 
subtilis and Micrococcus luteus [38]. Kalyoncu et al. [36] tested antimicrobial activity 
of chloroform and ethanolic extracts from Clitocybe geotropa, the latter showing 
significant capacity against Bacillus cereus. 
The genus Cortinarius is one of the most diverse genera of mushrooms. Ethyl acetate 
extracts of C. ardesiacus, C. archeri, C. atrosanguineus, C. austrovenetus, C. 
austroviolaceus, C. coelopus, C. [Dermocybe canaria], C. clelandii, C. [D. kula], C. 
memoria-annae, C. persplendidus, C. sinapicolor, C. vinosipes and others 47 collection 
samples not identified to species level, exhibited IC50 values of ≤ 0.09 mg/mL against 
Staphylococcus aureus [10]. However in a study reported by Ozen et al. [32], 
Cortinarius sp. methanolic extracts showed lower activity against Staphylococcus 
aureus. This demonstrates the effect of solvent extraction in the type and concentration 
of compounds present in the final extract and consequently the spectrum of 
antimicrobial activity. 
Ganoderma lucidum is one of the most famous traditional medicinal mushrooms. 
Various extracts have been found to be equally effective when compared with 
gentamycin sulphate, the acetone extract being the most effective. This mushroom had 
moderate inhibition against Bacillus subtilis and Staphylococcus aureus for any extract 
[39], but in the study reported by Sheena et al. [40] its methanolic extract showed poor 
antimicrobial activity. Other authors described the capacity of the aqueous extract to 
inhibit 15 types of Gram-positive and Gram-negative bacteria, with the highest 
inhibition exhibited against Micrococcus luteus [41]. 
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Ethyl acetate extracts of Phellinus sp., Gloeoporus thelephoroides and Hexagonia 
hydnoides inhibited Bacillus cereus growth while the same extract of Nothopanus 
hygrophanus mycelium presented inhibitory activity against Listeria monocytogenes 
and Staphylococcus aureus. Irpex lacteus mycelium extract was the most effective 
presenting a broad spectrum of activity [34].  
The antimicrobial activity of Pycnoporus sanguineus has been known since 1946, when 
Bose isolated poliporin, a compound active against Gram-positive and Gram-negative 
bacteria and without toxicity in experimental animals. Rosa et al. reported inhibition 
against Listeria monocytogenes and Staphylococcus aureus [34]. Smânia et al. [42, 43] 
showed that this mushroom produces cinnabarine, an orange pigment active against 
Bacillus cereus, Staphylococcus aureus, Leuconostoc mesenteroides, Lactobacillus 
plantarum and several Streptococcus spp. Cinnabarine was more active against Gram-
positive than Gram-negative bacteria [34]. 
The chloroform extract of Hygrophorus agathosmus and dichloromethane of Suillus 
collitinus were active against all the tested Gram-positive bacteria. The highest 
antibacterial activity was seen in the extract of H. agathosmus against Staphylococcus 
epidermidis and Bacillus subtilis, with MIC values 7.81 µg/mL lower than the reference 
antibiotic streptomycin (MIC = 15.62 µg/mL). MIC values (15.62 µg/mL) against 
Staphylococcus aureus were equal to the ones of streptomycin. Suillus collitinus 
showed MIC values much higher than the standard [44]. 
One non-edible mushroom, Hypholoma fasciculare (methanolic extract) presented high 
antimicrobial activity against Gram-positive bacteria namely Bacillus cereus, Bacillus 
subtilis and Staphylococcus aureus [37].  
All the tested Gram-positive bacteria were susceptible to methanolic extracts of 
Lactarius species and Tricholoma portentosum [32, 45, 46]. Among Lactarius species 
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(L. piperatus, L. camphorates, L. volemus, L. delicious), L. camphoratus methanolic 
extract was the one with greater antimicrobial activity [32]. Methanolic extracts of 
Ramaria botrytis and ethanolic extract of Ramaria flava inhibited the growth of Gram-
positive bacteria better than Gram-negative bacteria [47]. The antimicrobial effect of 
ethanolic extract of Laetiporus sulphureus was tested by Turkoglu et al. [48] and 
strongly inhibited the growth of the Gram-positive tested, including Bacillus subtilis, 
Bacillus cereus, Micrococcus luteus and Micrococcus flavus.  
Lepista nuda methanolic extract had a good action on Gram-positive bacteria, more 
specifically on Bacillus cereus, Bacillus subtilis and Staphylococcus aureus [37, 49].  
Ishikawa et al. reported the inhibitory activity of Lentinus edodes ethyl acetate extract 
against Bacillus cereus, Bacillus subtilis, Staphylococcus aureus, and Staphylococcus 
epidermidis [11]. This mushroom (aqueous extract) as also the n-BuOH fraction of 
Phellinus linteus methanol extract demonstrated good activity against MRSA [50, 51]. 
Furthermore, Streptococcus pyogenes was very sensitive to Lentinus edodes chloroform 
extract [52]. The ability of L. edodes extracts to improve oral health has also been 
extensively researched, since it showed strong bactericidal effect upon Streptococcus 
mutans that is strongly implicated in dental caries and tooth decay [53, 54].  
Mycelium of Leucopaxillus giganteus (methanolic extract) presented antimicrobial 
capacity, inhibiting only Gram-positive bacteria and in the decreasing order 
Staphylococcus aureus > Bacillus cereus > Bacillus subtilis [55]. The authors stated that 
the most promising nitrogen source to produce mushrooms with increased content in 
bioactive compounds that inhibit Gram positive bacteria growth was (NH4)2HPO4 . 
Methanolic extract of Phellinus rimosus and Navesporus floccosa showed moderate 
inhibition of Bacillus subtilis and Staphylococcus aureus [40].  
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Pleurotus ostreatus and Meripilus giganteus showed broad-spectrum antimicrobial 
activity. The maximum effect was shown by ethanolic extracts of Pleurotus ostreatus 
against Sarcina lutea [35]. 
Ether extract of Pleurotus sajor-caju showed high antibacterial activity against 
Staphylococcus aureus, whereas Staphylococcus epidermidis showed high sensitivity 
for ethanol extract [33]. 
Overall, it should be pointed out that the most susceptible Gram positive bacteria to 
mushrooms inhibitory action are Staphylococos aureus, Bacillus cereus and Bacillus 
subtilis. Agaricus bisporus [15, 32, 33], Agaricus bitorquis [15], Boletus edulis [31, 32], 
Cantharellus cibarius [31, 32, 37], Lentinus edodes [11, 50, 54], and different 
Cortinarius sp. [10], seem to be a good option to inhibit Staphylococos aureus, and in 
some cases Bacillus cereus and Bacillus subtilis. Studies with microorganisms related to 
nosocomial infections and multiresistance cases such as Enterococcus faecalis, 
Enterococcus faecium and MRSA are scarce. Nevertheless, in the few studies available, 
Lentinus edodes [50] was reported to inhibit Enterococcus faecalis, Enterococcus 
faecium and MRSA. The latter micrrorganism was also inhibited by Phellinus linteus 
[51] and Pleurotus ostreatus [50]. It is important to develop new studies with different 
mushroom species and, moreover, with these microorganisms so problematic to human 
health. 
 
Antimicrobial compounds from mushrooms 
Most studies on mushrooms with antibacterial activity, describes the action of its 
extracts without identifying the compounds responsible for this activity. However, some 
compounds have been described as active against Gram-positive bacteria (Table 2). 
Five of these compounds are terpenes. Confluentin (1a), Grifolin (1b) and Neogrifolin 
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(1c) from Albatrellus fletti had activity against Bacillus cereus and Enterococcus 
faecalis. The best result was for Enterococcus faecalis (MIC 0.5 to 1.0 mg/mL) [56]. 
Ganomycin A and B (5 a, b), isolated from Ganoderma pfeifferi, showed activity 
against Bacillus subtilis, Micrococcus flavus and Staphylococcus aureus (15-25 mm 
zones of inhibition at a concentration of 250µg/mL [57]. 
A steroid, 3,11-dioxolanosta-8,24(Z)-diene-26-oic acid (2), was isolated from 
Jahnoporus hirtus mushroom and revealed activity against Bacillus cereus and 
Enterococcus faecalis [56]. 
Four sesquiterpenes with antimicrobial activity were described. The Enokipodins A, B, 
C and D (4a-d), isolated from mycelium of Flammulina velutipes, with activity against 
Bacillus subtilis, but only Enokipodins A and C showed activity against Staphylococcus 
aureus [58]. 
Oxalic acid (3), an organic acid, isolated from mycelium of Lentinus edodes, showed 
activity against Bacillus cereus, Staphylococcus aureus and Streptococcus faecalis [59]. 
Coloratin A (10), a benzoic acid derivative isolated from Xylaria intracolarata, 
inhibited Staphylococcus aureus [60]. 
Eight compounds anthraquinones derivatives were also reported due to their 
antibacterial activities. 6-Methylxanthopurpurin-3-O-methyl ether (7), (1S, 3S)-
Austrocortilutein (8a), (1S,3R)-Austrocortilutein (8b), (1S,3S)-Austrocortirubin (8c) and 
Torosachrysone (8d), isolated from the mushroom Cortinarius basirubencens, 
and  Physcion (9a), Erythroglaucin (9b) and Emodin (9c) isolated from other species of 
Cortinarius were all effective against Staphylococcus aureus [10]. 
In addition to the LMW compounds already mentioned, several antimicrobial 
compounds with HMW have also been described, in particular proteins and peptides. 
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CSAP (Cordyceps sinensis Antibacterial Protein-N-terminal sequence ALATQHGAP) 
isolated from Cordyceps sinensis, showed strong activity against Staphylococcus aureus 
and poor activity against Bacillus subtilis. However, the antibacterial action of this 
protein was bacteriostatic [61]. 
The Ribonuclease isolated from Pleurotus sajor-caju had activity against 
Staphylococcus aureus, acting on RNA [62]. 
The peptide Plectasin, isolated from Pseudoplectania nigrella, is a macromolecule 
belonging to the class of defensins, present in animals and plants, which acts at the cell 
wall, more specifically in the synthesis of peptidoglycan. This peptide showed activity 
against Bacillus cereus, Bacillus thuringiensis, Corynebacterium diphtheriae, 
Corynebacterium jeikeium, Enterococcus faecalis, Enterococcus faecium, vancomycin-
resistant Enterococcus faecium (VREF), Staphylococcus aureus, 
MRSA, Staphylococcus epidermidis, methicillin-resistant Staphylococcus epidermidis 
(MRSE), Streptococcus pneumonia, penicillin-resistant Streptococcus pneumonia 
(PRSP), Streptococcus pyogenes and erythromycin-resistant Streptococcus pyogenes 
(ERSP). The in vitro action of Plectasin against Streptococcus pneumoniae is 
comparable to the action of penicillin and vancomycin [63]. 
The peptides Peptaibol Boletusin, Pepteibol Chrysospermin 3 and Peptaibol 
Chrysospermin 5 (isolated from Boletus spp.), allow the opening of pores for ions 
transport, and showed activity against Bacillus subtilis, Corynebacterium lilium and 
Staphylococcus aureus. The Peptaibol Chrysospermin 3 also had activity against 
Streptococcus sp. [64]. 
Fraction B from Pycnoporus sanguineus obtained by Smânia et al. [42], whose main 
constituent is a phenoxazin-3-one type pigment, showed activity against Staphylococcus 
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aureus and Streptococcus A, B, C and G. Lower values of MIC were obtained against 
Streptococcus strains. 
The mechanisms of action of most of the compounds described above are not available 
in literature. 
 
Antimicrobial activity against gram negative bacteria 
Methodologies 
The same methodologies already described for Gram positive bacteria are also used in 
the evaluation of mushroom extracts or compounds antimicrobial activity against Gram 
negative bactéria. The results are presented in Tables 3 and 4. 
 
Mushroom extracts with antimicrobial activity 
The antimicrobial activity against Gram negative bacteria showed by different 
mushroom extracts is not so extensive and is shown in Table 3. 
The results for Agaricus bisporus are contradictory. Barros et al. [31] and Öztürk et al. 
[15] found no activity against Gram negative bacteria, while Ozen et al. [32] and 
Tambeker et al. [33] reported positive activity mainly against Escherichia coli, but also 
against Pseudomonas aeruginosa, Enterobacter aerogenes, Klebsiella pneumoniae, 
Proteus vulgaris, Salmonella typhi and Salmonella typhimurium.	   However, these 
divergences may be due to different methods and concentrations used. Agaricus 
bitorquis methanolic extract had some effects against three of Gram negative bacteria 
namely Yersinia enterocolitica, Klebsiella pneumoniae and Proteus vulgaris [15]. 
Agaricus essettei, Agaricus silvicola, Agaricus silvaticus and Agaricus cf. nigrecentulus 
did not show any antibacterial activity against Gram negative bacteria [15, 31, 34]. 
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Ethanolic extracts of Armillaria mellea fruiting bodies revealed better antimicrobial 
activity than chloroform extracts and mycelium extract upon Gram negative bacteria 
[35, 36]. 
According to Barros et al. [31, 37] Cantharellus cibarius showed no activity against 
Gram negative bacteria as opposed to Ozen et al. [32] which showed activity against 
Escherichia coli and Pseudomonas aeruginosa. 
Enterobacter aerogenes and Escherichia coli were inhibited by methanolic extract of 
Clitocybe alexandri [38]. Clitocybe geotropa chloroform and ethanolic extracts 
inhibited the growth of all Gram-negative bacteria tested, being Proteus vulgaris the 
most sensitive [36].  
Beatttie et al. [10] report the anti-Pseudomonas aeruginosa activity of the genus 
Cortinarius and its subgenus, Dermocybe (methanolic extracts). The species tested were 
four, namely C. abnormis, C. austroalbidus, C. [D. kula], C. persplendidus, and eleven 
Cortinarius collection samples not identified to species level, obtaining IC50 values ≤ 
0.09 mg/mL against P. aeruginosa. 
Acetone extract from Ganoderma lucidum had strong antibacterial activity mainly 
against Klebsiella pneumonia [39]. Further studies indicate that the antimicrobial 
combination of G. lucidum extracts with chemotherapeutic agents (ampicillin, cefazolin, 
oxytetracycline, and chloramphenicol) resulted in synergism or antagonism, with 
synergism observed when combined with cefazolin against Bacillus subtilis and 
Klebsiella oxytoca [40, 65]. 
Mycelium extract from Leucoagaricus cf. cinereus, Marasmius cf. bellus and 
Marasmius sp. were capable of inhibiting the growth of Escherichia coli. Within the 
family Tricholomataceae, species from the genus Marasmius have long been known to 
produce interesting secondary metabolites [66]. 
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Hydnum repandum methanolic extract was mainly active against Pseudomonas 
aeruginosa. Escherichia coli was found to be the most sensitive bacteria to methanolic 
extracts of Lactarius species [32]. However, it was not observed activity of Lactarius 
delicious against E. coli [45, 46]. 
Laetiporus sulphureus ethanolic extract had a lower antibacterial spectrum against 
Gram negative bacteria, having no activity against Klebsiella pneumonia [48].  
On three occasions, namely with the Pseudomonas sp., Lentinus edodes aqueous extract 
was significantly more active than ciprofloxacin (positive control), whereby it gave 
markedly greater zones of inhibition. This result is of important clinical significance, as 
P. aeruginosa is emerging as a major aetiological of nosocomial infection [50]. L. 
edodes mycelium had no effect on Escherichia coli, Pseudomonas fluorescens, 
Klebsiella pneumoniae and Camphylobacter jejuni [52].   
Extracts from Lentinus edodes showed strong bactericidal effect against Prevotella 
intermedia, which is associated with gingivitis. This mushroom was capable of 
significantly reducing dental plaque deposition [53, 54, 67, 68]. 
Lepista nuda methanolic extract was effective against Escherichia coli and 
Pseudomonas aeruginosa [49]. 
Tambeker et al. [33] reported the antimicrobial ability of several extracts of Pleurotus 
sajor-caju. Escherichia coli, Enterococcus aerogenes, Pseudomonas aeruginosa and 
Klebsiella pneumoniae were most sensitive to ethanolic, methanolic and xylene 
extracts. 
Overall, among the tested Gram negative bacteria, Escherichia coli and Klebsiella 
pneumoniae are the most susceptible to mushrooms inhibitory effect. Agaricus bisporus 
[32, 33], Lentinus edodes [50, 54], Ganoderma lucidum [39, 40] and Lepista nuda [49] 
seem to have the higher antimicrobial activity against those microorganisms. 
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Pseudomonas aeruginosa was inhibited by Clitocybe alexandri [38], Boletus edulis, 
Cantharellus cibarius [32], Ganoderma lucidum [39] and Cortinarius sp. [10] extracts. 
Studies with Enterobacter aerogenes and Serratia marcescens are scarce, and due to the 
importance in multiresistance area, they should be carrried out to assess sensibility to 
extracts from mushroom species. 
 
Antimicrobial compounds from mushrooms 
Some of the compounds discussed in section 2.2. and other have also been described for 
their action against Gram-negative bacteria (Table 4).	  
Terpenes 5a and 5b isolated from Ganoderma pfeifferi, showed moderate activity 
against Escherichia coli, Proteus mirabilis and Serratia marcescens [57].	  
The organic acid 3, isolated from mycelium of Lentinus edodes,	  showed activity against 
Klebsiella pneumoniae, Proteus vulgaris, Pseudomonas aeruginosa and Pseudomonas 
fluorescens [59].	  
The benzoic acid derivative 10 isolated from Xylaria intracolarata, showed activity 
against Escherichia coli, Klebsiella pneumonia, Pseudomonas aeruginosa and 
Salmonella enteritidis.	  For this compound the highest inhibition (22 mm) was found in 
Klebsiella pneumonia, higher than the control (gentamicin, 14 mm) [60]. 
Compounds 7, 8a-d (Cortinarius basirubescens) and 9a-c (Cortinarius spp.) were 
effective against Pseudomonas aeruginosa [10].	  
The quinoline 6, isolated from Leucopaxillus albissimus, showed activity against 
Achromobacter xyloxidans, Acinetobacter baumannii, Burkholderia cenocepacia, 
Burkholderia cepacia, Burkholderia multivorans, Cytophaga johnsonae, and 
Pseudomonas aeruginosa.	   Among the thirteen microorganisms tested, Cytophaga 
johnsonae was the most strongly inhibited (16 mm) [69].	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Some proteins have also been reported against Gram-negative bacteria.	  The protein 
CSAP isolated from Cordyceps sinensis and already mentioned above, showed activity 
against Escherichia coli, Proteus vulgaris and Salmonella typhi [61], while the protein 
(N-terminal sequence SVQATVNGDKML) isolated from Clitocybe sinopica was active 
against Agrobacterium rhizogenes, Agrobacterium tumefaciens, Agrobacterium vitis, 
Xanthomonas malvacearum and Xanthomonas oryzae [70].	  
Ribonuclease (Pleurotus sajor-caju) had activity against Pseudomonas aeruginosa and 
Pseudomonas fluorescens, acting at RNA level [62].	  
Fraction B (Pycnoporus sanguineus) showed activity against Escherichia coli, 
Klebsiella pneumoniae, Pseudomonas aeruginosa and Salmonella typhi [42]. 	  
Unfortunatly, the mechanism of action of each one of the isolated compounds is not 
completly clear and described in the available reports.  
 
Concluding remarks 
The present review focuses on antimicrobial effects of mushrooms from all over the 
world, and their isolated compounds. It will be certainly useful for future scientific 
studies. Both edible and not edible mushrooms show antimicrobial activity against 
pathogenic microorganisms, including bacteria associated with nosocomial infections 
(Pseudomonas aeruginosa, Pseudomonas maltophila, Listeria monocytogenes, 
Staphylococcus aureus, Klebsiella pneumoniae, Morganella morganii, Proteus 
mirabilis, Serratia marcescens) and multi-resistance  (MRSA, MRSE, VREF, PRSP, 
ERSP).  
Data available from literature indicates that mushroom extracts and isolated compounds 
exhibit higher antimicrobial activity against Gram-positive than Gram-negative bacteria. 
Among all the mushrooms, Lentinus edodes is the best studied species and seems to 
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possess broad antimicrobial action against both Gram-positive and Gram-negative 
bacteria. Species from the genera Boletus, Ganoderma and Lepista appear promising for 
future studies, if one considers the good activity and limited number of publications. 
Considering the low number of studies with individual compounds, Plectasin peptide, 
isolated from Pseudoplectania nigrella, revealed the highest antimicrobial activity 
against Gram-positive bacteria.  
The comparison of the results reported by different authors is dificult, due to the diverse 
methodologies used to evaluate antimicrobial activity of mushroom extracts or isolated 
compounds. Therefore, the standardization of methods and establishment of cut-off 
values is urgent. The knowledge about the mechanisms of action of different 
compounds might leads to the discovery of new active principles for antimicrobial 
activity. Furthermore, the application of citotoxicity assays is also important to evaluate 
the effects on human in the range of the in vitro tested concentrations. 
The research on mushrooms is extensive and hundreds of species have been 
demonstrated a broad spectrum of pharmacological activities, including antimicrobial 
activity. Although there are a number of studies available in literature, they are almost 
entirely focused on screening of antibacterial properties of mushroom extracts. In fact, 
there is a gap on identification of individual compounds responsible for those 
properties, and only a few low molecular weight compounds and some peptides and 
proteins have been described. After eluciadation of their mechanism of action, these 
mushroom metabolites or other related compounds could be used to develop 
nutraceuticals or drugs effective against pathogenic microorganisms resistant to 
conventional treatments.  
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Table 1. Mushroom extracts with antimicrobial activity against Gram-positive bacteria.  
Microorganism Mushrooma Results References 
Actinomyces naeslundii Lentinus edodes CFU = 0 – 3.30 (±5.48)×10
6 
MIC = 0.05 – 20 mg/mL [53,54,67] 
Actinomyces viscosus Lentinus edodes MIC = 0.05 – 20 mg/mL [54] 
Bacillus cereus 
Agaricus bisporus, Agaricus bitorquis, Agaricus essettei, Agaricus silvicola, Armillaria mellea, Boletus 
edulis, Cantharellus cibarius, Clitocybe alexandri, Clitocybe geotropa, Cortinarius sp., Gloeoporus 
thelephoroides, Hexagonia hydnoides, Hydnum repandum, Hypholoma fasciculare, Irpex lacteus (M), 
Lactarius camphorates, Lactarius delicious, Lactarius piperatus, Lactarius volemus, Laetiporus 
sulphureus, Lentinus edodes, Lepista nuda, Leucopaxillus giganteus (M), Macrolepiota procera, Meripilus 
giganteus (M), Meripilus giganteus, Phellinus sp., Pleurotus ostreatus (M), Pleurotus ostreatus, Ramaria 
botrytis, Ramaria flava, Rhizopogon roseolus, Sarcodon imbricatus, Sparassis crispa, Tricholoma 
portentosum 
IZD = 5 – 21 mm 
MIC = 5 µg/mL – 100 
mg/mL 
[11,15, 31,32, 
34-38,45-48, 
50, 55] 
 
Bacillus megaterium Lentinus edodes CFU = 0 (total inhibition) [52] 
Bacillus pumilis Lentinus edodes IZD = 14 mm [50] 
Bacillus subtilis 
Agaricus bisporus, Agaricus bitorquis, Agaricus essettei, Agaricus silvicola,  Armillaria mellea, 
Cantharellus cibarius, Clitocybe alexandri, Clitocybe geotropa, Cortinarius sp., Ganoderma lucidum, 
Hygrophorus agathosmus, Hypholoma fasciculare, Lactarius delicious, Lactarius piperatus, Laetiporus 
sulphureus, Lentinus edodes, Lepista nuda,  
Leucopaxillus giganteus (M), Meripilus giganteus (M), Navesporus floccosa, Paxillus involutus (M), 
Phellinus rimosus, Pleurotus ostreatus (M), Pleurotus ostreatus, Ramaria botrytis, Ramaria flava, 
Rhizopogon roseolus, Sparassis crispa, Suillus collitinus, Tricholoma acerbum, Tricholoma portentosum 
IZD = 5 –28mm 
MIC = 5 µg/mL – 300 
mg/mL 
 
[11,15,31, 35-
40,44-50,54, 
55,71] 
 
Enterococcus faecalis Lentinus edodes IZD = 8 mm [50] 
Enterococcus faecium Lentinus edodes MIC  >1.5 – >50 mg/mL [54] 
Lactobacillus casei Lentinus edodes 
CFU = 5.00 (±7.07)×10-1 –
9.28 (±2.76)×102 
MIC = 0.05 – 15 mg/mL 
[53,54,67]  
Listeria innocua Lentinus edodes IZD = 8 mm [11] 
Listeria monocytogenes Lentinus edodes, Pycnoporus sanguineus (M), IZD = 11 – 13mm [11,34,50] 
Staphylococcus sp. Lentinus edodes IZD = 12 mm [50] 
Staphylococcus aureus 
Agaricus bisporus, Agaricus bitorquis, Agaricus essettei, Agaricus silvícola, Armillaria mellea, Boletus 
edulis, Cantharellus cibarius, Clitocybe geotropa, Cortinarius sp., Cortinarius abnormis, Cortinarius 
ardesiacus, Cortinarius archeri, Cortinarius austroalbidus, Cortinarius austrovenetus, Cortinarius 
austroviolaceus, Cortinarius coelopus, Cortinarius clelandii, Cortinarius [Dermocybe sp, Dermocybe 
canaria, Dermocybe kula], Cortinarius fulvoiubatus, Cortinarius ianthinus, Cortinarius memoria-annae, 
CFU = 2.1×104 
IZD = 8 – 24 mm 
MIC = 5µg/mL –50 mg/mL 
IC50  <0.01 – ≥2.00 mg/mL 
[10,11,15,31- 
37,39,40, 44, 
46-50,52,54, 
55] 
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Cortinarius persplendidus, Cortinarius sinapicolor, Cortinarius submagellanicus, Cortinarius 
tricholomoides, Cortinarius vinosipes, Ganoderma lucidum, Hydnum repandum, Hygrophorus agathosmus, 
Hypholoma fasciculare, Irpex lacteus (M), Lactarius camphoratus, Lactarius delicious, Lactarius 
piperatus, Lactarius volemus, Laetiporus sulphureus, Lentinus edodes, Lepista nuda, Leucopaxillus 
giganteus (M), Macrolepiota procera, Meripilus giganteus (M), Meripilus giganteus, Morchella elata (M), 
Morchella esculenta var. vulgaris (M), Navesporus floccosa, Nothopanus hygrophanus (M), Paxillus 
involutus (M), Phellinus rimosus, Pleurotus eryngii (M), Pleurotus ostreatus (M), Pleurotus sajor-caju, 
Pycnoporus sanguineus (M), Ramaria botrytis, Ramaria flava, Sparassis crispa, Suillus collitinus 
MRSA Lentinus edodes, Phellinus linteus IZD = 12 mm MIC = 500 µg/mL [50,51] 
Staphylococcus 
epidermidis  Agaricus bisporus, Hygrophorus agathosmus, Lentinus edodes, Pleurotus sajor-caju, Suillus collitinus 
IZD = 11 – 27mm 
MIC = 7.81 – 62.5 µg/mL [11,33,44,50]  
Streptococcus gordonii Lentinus edodes MIC = 0.075 – 50 mg/mL [54] 
Streptococcus mitis Lentinus edodes MIC = 0.075 – 15 mg/mL [54] 
Streptococcus mutans Lentinus edodes CFU = 2.15 (±5.58)×10
5 
MIC = 0.1 – 10 mg/mL	   [53,54,67] 
Streptococcus oralis Lentinus edodes MIC = 0.1 – >50 mg/mL [54] 
Staphylococcus 
saprophyticus Agaricus cf. nigrecentulus (M), Tyromyces duracinus (M) IZD >12 mm [34] 
Streptococcus pyogenes Lentinus edodes CFU = 6.0×104 [52] 
Streptococcus salivarius Lentinus edodes MIC = 0.1 – 10 mg/mL [54] 
Streptococcus sanguinis Lentinus edodes 
CFU = 2.53 (±0.62)×106 – 
5.06 (±1,58)×106 
MIC = 0.075 – 50 mg/mL 
[53,54,67] 
Streptococcus sobrinus Lentinus edodes MIC = 0.075 – 20 mg/mL [54] 
Micrococcus flavus Agaricus bisporus, Agaricus bitorquis, Agaricus essettei, Laetiporus sulphurous, Ramaria flava IZD = 20 – 23 ± 1 mm [15,47,48] 
Micrococcus luteus Agaricus bisporus, Agaricus bitorquis, Agaricus essettei, Clitocybe alexandri, Laetiporus sulphurous, Lentinus edodes, Ramaria flava IZD = 10 – 21±1mm 
[15,38,47,48,
52]  
Sarcina lutea 
Armillaria mellea (M), Armillaria mellea, Clitocybe geotropa, Meripilus giganteus (M), Meripilus 
giganteus, Morchella costata (M), Morchella esculenta var. vulgaris (M), Paxillus involutus (M), Pleurotus 
ostreatus (M), Sparassis crispa 
IZD = 8 – 27 mm [35,36] 
a Acetone, chloroform, ethanol, ethyl acetate, methanol, dichloromethane, ether, xylene or water extracts. 
M- mycelium, the other samples refer to fruiting body; MRSA- Methicillin-resistant Staphylococcus aureus. 
The antimicrobial activity was expressed in CFU (colony-forming unities), MIC (minimal inhibitory concentrations), IZD (internal zone diameter) or IC50 (concentrations 
inhibiting 50% of the growth) values.   
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Table 2. Mushroom compounds with antimicrobial activity against Gram-positive bacteria.  
Microorganism Compound (mushroom) Results References 
Bacillus cereus 
Confluentin (1a), Grifolin (1b) and Neogrifolin (1c) (Albatrellus flettii); 3,11-Dioxolanosta-
8,24(Z)-diene-26-oic acid (2) (Jahnoporus hirtus); Oxalic acid (3) (Lentinus edodes M); Proteins 
and peptides: Plectasin (Pseudoplectania nigrella) 
IZD = 17 mm 
MIC = 10 µg/mL – ≥128 mg/L [56,59,63] 
Bacillus subtilis 
Peptides: Peptaibol  Boletusin, Peptaibol  Chrysospermin 3 and Peptaibol  Chrysospermin 5 
(Boletus spp.); Protein (Cordyceps sinensis); Enokipodins A, B, C and D (4a-d) (Flammulina 
velutipes M); Ganomycin A and B (5a,b) (Ganoderma pfeifferi) 
MIC  > 100000 g/L  
 IZD = 11 – 28 mm [57,58,61,64] 
Bacillus thuringiensis Plectasin (Pseudoplectania nigrella) MIC = 0.5 mg/L [63] 
Corynebacterium diphtheriae Plectasin (Pseudoplectania nigrella) MIC = 8 mg/L [63] 
Corynebacterium jeikeium Plectasin (Pseudoplectania nigrella) MIC = 2 mg/L [63] 
Corynebacterium lilium Peptaibol  Boletusin, Peptaibol  Chrysospermin 3 and Peptaibol  Chrysospermin 5 (Boletus spp.) IZD = 23 – 25 mm [64] 
Enterococcus faecalis 1a, 1b and 1c (Albatrellus flettii); 2 (Jahnoporus hirtus); Plectasin (Pseudoplectania nigrella) MIC = 0.5µg/mL – ≥128 mg/L [56,63] 
Enterococcus faecium; VREF Plectasin (Pseudoplectania nigrella) MIC = 32 – 64 mg/L [63] 
Micrococcus flavus 5a,b (Ganoderma pfeifferi) IZD = 25 – 26 mm [57] 
Staphylococcus aureus 
Peptaibol  Boletusin, Peptaibol  Chrysospermin 3 and Peptaibol  Chrysospermin 5 (Boletus spp.); 
Proteins (Cordyceps sinensis); 6-Methylxanthopurpurin-3-O-methyl ether (7), (1S,3S)-
Austrocortilutein (8a), (1S,3R)- Austrocortilutein (8b), (1S,3S)-Austrocortirubin (8c) and 
Torosachrysone (8d) (Cortinarius basirubencens); Physcion (9a), Erythroglaucin (9b) and 
Emodin (9c) (Cortinarius sp.); 4a-d (Flammulina velutipes M); 5a,b (Ganoderma pfeifferi); 3 
(Lentinus edodes M);; Ribonuclease (Pleurotus sajor-caju); Plectasin (Pseudoplectania 
nigrella);Fraction B (Pycnoporus sanguineus); Coloratin A (10) (Xylaria intracolarata) 
IZD = 12 – 24 mm 
MIC = 0.156 mg/L – 50000 g/L 
IC50 =  0.7 – >50 µg/mL 
IC50 = 34 ± 4 µM 
[10,42,57-64]  
MRSA Plectasin (Pseudoplectania nigrella); MIC = 32 mg/L [63] 
Staphylococcus epidermidis; 
MRSE Plectasin (Pseudoplectania nigrella) MIC = 8 mg/L [63] 
Streptococcus sp. Peptaibol  Chrysospermin 3 (Boletus spp.) IZD = 9 mm [60] 
Streptococcus faecalis 3 (Lentinus edodes M) IZD = 13 mm [59] 
Streptococcus group A.B,C,G Fraction B (Pycnoporus sanguineus) MIC = 0.019 – 0.039 mg/mL [42] 
Streptococcus pneumonia; 
PRSP Plectasin (Pseudoplectania nigrella) MIC = 0.5 mg/L [63] 
Streptococcus pyogenes; 
ERSP Plectasin (Pseudoplectania nigrella) MIC = 0.125 mg/L [63] 
M- mycelium, the other samples refer to fruiting body. The antimicrobial activity was expressed in MIC (minimal inhibitory concentrations), IZD (internal zone diameter) or 
IC50 (concentrations inhibiting 50% of the growth) values. VREF - Vancomycin-resistant Enterococcus faecium ; MRSA- Methicillin-resistant Staphylococcus aureus;  
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MRSE - Methicillin-resistant Staphylococcus epidermidis; PRSP - Penicillin-resistant Streptococcus pneumonia; ERSP - Erythromycin – resistant Streptococcus pyogenes 
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Table 3. Mushroom extracts with antimicrobial activity against Gram-negative bacteria.  
Microorganism Mushrooma Results References 
Cupriavidis Lentinus edodes IZD = 15 mm [50] 
Enterobacter aerogenes 
Agaricus bisporus, Clitocybe alexandri, Hygrophorus agathosmus, Meripilus giganteus (M), 
Paxillus involutus (M), Pleurotus ostreatus (M), Pleurotus sajor-caju, Rhizopogon roseolus, 
Suillus collitinus 
IZD = 8 – 22mm 
MIC = 15.62 – 125 µg/mL [33,35,38,44] 
Enterobacter cloacae Armillaria mellea, Clitocybe geotropa, Meripilus giganteus (M), Meripilus giganteus, Paxillus involutus (M), Pleurotus ostreatus (M), Sparassis crispa IZD = 10 – 20 mm [35,36] 
Enterobacter faecalis Armillaria mellea, Clitocybe geotropa, Meripilus giganteus (M), Meripilus giganteus, Sparassis crispa IZD = 8 – 14 mm [35,36] 
Escherichia coli 
Agaricus bisporus, Armillaria mellea (M), Armillaria mellea, Boletus edulis, Cantharellus 
cibarius, Clitocybe alexandri, Clitocybe geotropa, Cortinarius sp., Ganoderma lucidum, 
Hydnum repandum, Irpex lacteus (M), Lactarius camphoratus, Lactarius delicious, Lactarius 
piperatus, Lactarius volemus, Laetiporus sulphureus, Lentinus edodes, Lepista nuda, 
Leucoagaricus cf. cinereus (M), Macrolepiota procera, Marasmius sp. (M), Marasmius cf. 
bellus (M), Meripilus giganteus (M), Meripilus giganteus, Morchella costata ((M), 
Morchella hortensis (M), Navesporus floccosa, Paxillus involutus (M), Phellinus rimosus, 
Pleurotus eryngii (M), Pleurotus ostreatus (M), Pleurotus sajor-caju, Rhizopogon roseolus, 
Sparassis crispa, Suillus collitinus 
IZD = 8 – 27.40 ± 0.19 mm 
MIC = 250 µg/mL –  >50mg/mL 
[32-36,38-40, 
44, 46,48-
50,54,71]  
Fusobacterium nucleatum Lentinus edodes 
CFU = 2.40 (±3,11)×102 –  7.56 
(±4.28)×106 
MIC = 0.9 – 20 mg/mL 
[53,54,67] 
Klebsiella aerogenes Lentinus edodes IZD = 9 mm [50] 
Klebsiella pneumoniae Agaricus bisporus, Agaricus bitorquis, Ganoderma lucidum, Lactarius piperatus, Lentinus edodes, Lepista nuda, Pleurotus sajor-caju, Ramaria flava 
IZD = 4 – 31.60 ± 0.10 mm 
MIC = 0.5 mg/mL 
[11,15,33,39, 
46,47,49,50, 
55]  
Morganella morganii Agaricus bisporus, Agaricus bitorquis, Agaricus essettei, Laetiporus sulphurous IZD = 4.5 ± 0.5 mm [15,48] 
Neisseria subflava Lentinus edodes CFU = 9.49 (±2.60)×10
6 – 1.50 
(±0,50)×108 [53,67] 
Porphyromonas gingivalis Lentinus edodes MIC = 0.05 – 10 mg/mL [45] 
Prevotella intermedia Lentinus edodes 
CFU = 2.00 (±2.83)×101 –  2.60 
(±6.66)×105 
MIC = 0.05 – 15mg/mL 
[53,54,67,68] 
Prevotella nigrescens Lentinus edodes MIC = 0.1 – 15mg/mL [54] 
Proteus mirabilis Lentinus edodes IZD = 4 mm [11] 
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Proteus vulgaris 
Agaricus bisporus, Agaricus bitorquis, Armillaria mellea, Clitocybe geotropa, Laetiporus 
sulphureus, Meripilus giganteus (M), Meripilus giganteus, Pleurotus ostreatus (M), 
Pleurotus sajor-caju, Sparassis crispa 
IZD = 5.5 ± 0.5 – 19 mm [15,33,35,36, 48]  
Pseudomonas aeruginosa 
Agaricus bisporus, Boletus edulis, Cantharellus cibariusCortinarius sp., Cortinarius 
abnormis, Cortinarius ardesiacus, Cortinarius archeri, Cortinarius austroalbidus, 
Cortinarius austrovenetus, Cortinarius austroviolaceus, Cortinarius coelopus, Cortinarius 
clelandii, Cortinarius [Dermocybe sp., Dermocybe canaria, Dermocybe kula], Cortinarius 
fulvoiubatus, Cortinarius ianthinus, Cortinarius memoria-annae, Cortinarius persplendidus, 
Cortinarius sinapicolor, Cortinarius submagellanicus, Cortinarius tricholomoides, 
Cortinarius vinosipes, Ganoderma lucidum, Hydnum repandum, Lactarius camphoratus, 
Lactarius delicious, Lactarius piperatus, Lactarius volemus, Laetiporus sulphureus, Lentinus 
edodes, Lepista nuda, Macrolepiota procera, Navesporus floccosa, Phellinus rimosus, 
Pleurotus sajor-caju, Ramaria flava 
IZD = 6 – 20 mm 
MIC = 0.5 – 100 mg/mL 
IC50 = 0.04 –  >2.00 mg/mL 
[10,32,33,39, 
40,45,46,48-
50]  
Pseudomonas maltophila Lentinus edodes IZD = 6 mm [11] 
Salmonella enteritidis Laetiporus sulphureus, Ramaria flava IZD = 4 – 5 ± 1 mm [37,40] 
Salmonella poona Lentinus edodes IZD = 9 mm [50] 
Salmonella typhi Agaricus bisporus, Ganoderma lucidum, Pleurotus sajor-caju IZD = 7.00 ± 0.18 – 20.60 ± 0.14 mm [33,39] 
Salmonella typhimurium 
Agaricus bisporus, Armillaria mellea (M), Armillaria mellea, Clitocybe geotropa, 
Ganoderma lucidum, Hygrophorus agathosmus, Irpex lacteus (M), Lepista nuda, Meripilus 
giganteus (M), Meripilus giganteus, Morchella costata (M), Morchella elata (M), Morchella 
esculenta var. vulgaris (M), Morchella hortensis (M), Navesporus floccosa, Paxillus 
involutus (M), Phellinus rimosus, Pleurotus ostreatus (M), Pleurotus sajor-caju, Sparassis 
crispa, Suillus collitinus,  
IZD = 6 – 16 mm 
MIC = 15.62 – 125 µg/mL 
[33-36, 
40,44,49] 
Serratia marcescens Lentinus edodes IZD = 10 mm [50] 
Veillonella dispar Lentinus edodes CFU = 1.37 (±0.31)×10
7 – 2.35 
(±1.09)×107 [53,67] 
Veillonella parvula Lentinus edodes MIC = 0.3 – 20 mg/mL [54] 
Yersinia enterecolitica Agaricus bitorquis, Laetiporus sulphureus, Lentinus edodes, Ramaria flava IZD = 5 – 16 mm [11,15,47] 
a  Acetone, chloroform, ethanol, ethyl acetate, methanol, dichloromethane, ether, xylene or water extracts. 
M- mycelium, the other samples refer to fruiting body. 
The antimicrobial activity was expressed in CFU (colony-forming unities), MIC (minimal inhibitory concentrations), IZD (internal zone diameter) or IC50 (concentrations 
inhibiting 50% of the growth) values.   
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Table 4. Mushroom compounds with antimicrobial activity against Gram-negative bacteria.  
Microorganism Compound (mushroom) Results References 
Achromobacter xyloxidans 6 (Leucopaxillus albissimus) MIC = 32 µg/mL [69] 
Acinetobacter baumannii 6 (Leucopaxillus albissimus) MIC = 128 µg/mL [69] 
Agrobacterium rhizogenes Protein (Clitocybe sinopica) MIC = 0.14 µM [70] 
Agrobacterium tumefaciens Protein (Clitocybe sinopica) MIC = 0.14 µM [70] 
Agrobacterium vitis Protein (Clitocybe sinopica) MIC = 0.28 µM [70] 
Burkholderia cenocepacia 6 (Leucopaxillus albissimus) MIC = 16 µg/mL [69] 
Burkholderia cepacia 6 (Leucopaxillus albissimus) MIC = 32 µg/mL [69] 
Burkholderia multivorans 6 (Leucopaxillus albissimus) MIC = 16 µg/mL [69] 
Cytophaga johnsonae 6 (Leucopaxillus albissimus) IZD = 16 mm [69] 
Escherichia coli Proteins (Cordyceps sinensis); 5a,b (Ganoderma pfeifferi); Fraction B (Pycnoporus sanguineus); 10 (Xylaria intracolarata) 
IZD = 4 – 16 mm 
MIC = 0.625 mg/mL – 100000 g/L [42,57,60,61]  
Klebsiella pneumoniae 3 (Lentinus edodes M); Fraction B (Pycnoporus sanguineus); 10 (Xylaria intracolarata) IZD = 12 – 22 mm MIC = 0.625 mg/mL [42,59,60] 
Proteus mirabilis 5a,b (Ganoderma pfeifferi) IZD = 15 mm [57] 
Proteus vulgaris Protein (Cordyceps sinensis); 3 (Lentinus edodes M) IZD = 12 mm MIC = 75000 g/L [59,61] 
Pseudomonas aeruginosa 
7, 8a-8d (Cortinarius basirubencens); 9a-c (Cortinarius sp.); 3 (Lentinus edodes M); 6 
(Leucopaxillus albissimus); Ribonuclease (Pleurotus sajor-caju); Fraction B (Pycnoporus 
sanguineus); 10 (Xylaria intracolarata) 
IZD = 15 – 16 mm 
MIC = 128 µg/mL – 1.250 mg/mL 
IC50 = 1.5 – >50 µg/mL 
IC50 = 51 ± 6 µM 
[10, 42,59,62, 
64,68] 
Pseudomonas fluorescens 3 (Lentinus edodes M); Ribonuclease (Pleurotus sajor-caju) IZD = 13 mm IC50 = 186 ± 12 µM 
[59,62] 
Serratia marcescens 5a,b (Ganoderma pfeifferi) IZD = 15 – 16mm [57] 
Salmonella enteritidis 10 (Xylaria intracolarata) IZD = 16 mm [60] 
Salmonella typhi Protein (Cordyceps sinensis); Fraction B (Pycnoporus sanguineus) MIC = 0.312 mg/mL – 50000 g/L [42,61] 
Stenotrophomonas maltophilia 6 (Leucopaxillus albissimus) MIC = 32 µg/mL [69] 
Xanthomonas malvacearum Protein (Clitocybe sinopica) MIC = 0.56 µM [70] 
Xanthomonas oryzae Protein (Clitocybe sinopica) MIC = 0.56 µM [70] 
M- mycelium, the other samples refer to fruiting body. The antimicrobial activity was expressed in MIC (minimal inhibitory concentrations), IZD (internal zone diameter) or 
IC50 (concentrations inhibiting 50% of the growth) values. 
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Figure 1. Chemical structure of the low-molecular-weight (LMW) compounds with antimicrobial potential found in mushrooms. 
